Xaparin Injection 6000 Anti-Xa IU/0.6 ml contains Enoxaparin Sodium, a low molecular weight heparin (LMWH) used as an anticoagulant to prevent and treat blood clots. It is widely prescribed in hospital and outpatient settings for patients at risk of deep vein thrombosis (DVT), pulmonary embolism (PE), or other thromboembolic complications, particularly following surgery, immobilization, or certain cardiovascular conditions.

Enoxaparin is preferred for its predictable anticoagulant effects, allowing for subcutaneous administration without the need for frequent laboratory monitoring in most cases. Xaparin Injection 6000 Anti-Xa IU/0.6 ml offers a higher-dose option for patients requiring increased anticoagulation, ensuring effective prevention or treatment of thrombotic events.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

How Xaparin Injection Works

Enoxaparin Sodium works by enhancing the activity of antithrombin III, a natural inhibitor of clotting factors:

• Specifically inhibits factor Xa, reducing the formation and extension of blood clots

• Provides rapid and predictable anticoagulant effects after subcutaneous injection

• Prevents venous thromboembolism in high-risk patients

• Maintains anticoagulant activity with lower risk of complications compared to unfractionated heparin

• Supports treatment of DVT, PE, and acute coronary syndromes under proper medical supervision

By targeting factor Xa, Xaparin Injection effectively reduces the risk of life-threatening thromboembolic events while maintaining a favorable safety profile.

Indications

Xaparin Injection 6000 Anti-Xa IU/0.6 ml is indicated for:

• Prevention of DVT and PE in patients undergoing major orthopedic or abdominal surgery

• Treatment of DVT and PE, including patients with or without unstable angina or myocardial infarction

• Prophylaxis in medically ill patients with restricted mobility or increased clotting risk

• Adjunct therapy in acute coronary syndrome to reduce the risk of clot formation

• Patients requiring higher anticoagulant doses based on weight or clinical condition

This formulation is intended for short- or medium-term use as directed by a healthcare professional.

Dosage and Administration

• The usual dose is 6000 Anti-Xa IU (0.6 ml) subcutaneously, generally administered once daily for prophylaxis or as prescribed for therapeutic use.

• Administer deep into subcutaneous tissue, rotating injection sites to prevent local irritation.

• Intravenous administration is not recommended unless specifically directed by a physician.

• Routine coagulation monitoring is usually unnecessary but may be required in special populations, such as patients with renal impairment, obesity, or pregnancy.

Dosage may be adjusted according to patient weight, kidney function, and clinical condition.

Precautions

• Use under medical supervision in patients with active bleeding, severe liver or kidney disease, or a history of heparin-induced thrombocytopenia (HIT).

• Inform your healthcare provider of all medications being taken, particularly other anticoagulants, antiplatelets, or NSAIDs.

• Monitor for signs of bleeding, such as unusual bruising, blood in urine or stool, or prolonged bleeding from minor cuts.

• Discuss use in pregnancy and breastfeeding with a physician before administration.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Possible Side Effects

Common side effects may include:

• Pain, redness, or bruising at the injection site

• Mild swelling at the injection site

Rare but serious side effects may include:

• Severe bleeding (gastrointestinal, intracranial, or other sites)

• Thrombocytopenia (low platelet count)

• Allergic reactions, including rash, itching, or anaphylaxis

Seek immediate medical attention if severe bleeding, persistent dizziness, or signs of allergic reaction occur.

Storage

Store Xaparin Injection 6000 Anti-Xa IU/0.6 ml in a cool, dry place, protected from light. Do not freeze. Keep out of reach of children.

Xaparin Injection 6000 Anti-Xa IU/0.6 ml is a high-dose low molecular weight heparin for preventing and treating blood clots, reducing thromboembolic complications, and supporting safe anticoagulation therapy under professional supervision.